SCHEMBL1444670

SCHEMBL1444670

O=c1c2ccccc2oc2c(O)c(O)c(O)c(O)c12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 1/20 0.65
MAOA P21397 9/20 0.61
PTGS2 P35354 1/20 0.58
CYP3A4 P08684 3/20 0.53
KDM4E B2RXH2 2/20 0.53
ALDH1A1 P00352 2/20 0.53
HPGD P15428 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
HSD17B10 Q99714 2/20 0.53
GLA P06280 1/20 0.53
MAPT P10636 1/20 0.53
PGAM1 P18669 1/20 0.53
CASP1 P29466 1/20 0.53
CASP7 P55210 1/20 0.53
EGFR P00533 1/20 0.53
MGAM O43451 1/20 0.53
GAA P10253 1/20 0.53
SI P14410 1/20 0.53
MGAM2 Q2M2H8 1/20 0.53
MEN1 O00255 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31277141 0.85 KDM5A (0.49) KDM5AMAOAPTGS2CYP3A4KDM4E
SCHEMBL21666743 0.81 MAOA (0.67) KDM5AMAOAPTGS2CYP3A4KDM4E
SCHEMBL30436466 0.79 ESR2 (0.65) MAOACYP3A4KDM4EALDH1A1HPGD
SCHEMBL25200752 0.78 IKBKB (0.69) MAOAKDM4EMAPTMGAMGAA
SCHEMBL25196944 0.78 IKBKB (0.72) KDM5AMAOAKDM4EMAPTMGAM
SCHEMBL7237614 0.77 MAOA (0.65) KDM5AMAOAEGFR
SCHEMBL31258561 0.77 MAOA (0.65) KDM5AMAOAEGFR
SCHEMBL7232063 0.76 PTGS2 (0.69) KDM5AMAOAPTGS2CYP3A4KDM4E
SCHEMBL7365848 0.76 MAOA (0.75) KDM5AMAOAPTGS2CYP3A4KDM4E
SCHEMBL7050788 0.76 KDM5A (0.61) KDM5AMAOAPTGS2CYP3A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3654841-B1 TARGETED OSMOTIC LYSIS OF MALIGNANT CANCER CELLS USING PULSED MAGNETIC FIELD GRADIENTS BOARD OF SUPERVISORS OF LOUISIANA STATE UNIV (US) 2024-02-07 EP claimed
EP-3654841-A1 TARGETED OSMOTIC LYSIS OF MALIGNANT CANCER CELLS USING PULSED MAGNETIC FIELD GRADIENTS Board Of Supervisors Of Louisiana State University (US) 2020-05-27 EP claimed
CN-111132614-A Targeted osmotic lysis of malignant cancer cells using pulsed magnetic field gradients 路易斯安娜州立大学监测委员会,农业和机械学院 2020-05-08 CN claimed
WO-2019018207-A1 TARGETED OSMOTIC LYSIS OF MALIGNANT CANCER CELLS USING PULSED MAGNETIC FIELD GRADIENTS BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2019-01-24 WO claimed
CN-105218507-A A kind of Norathyriol derivative and its production and use UNIV CHINA PHARMA 2016-01-06 CN claimed
CN-104968799-A Assays and cell-based tests using a receptor na/k-atpase/src complex and uses thereof UNIV TOLEDO 2015-10-07 CN claimed
CN-102153536-B Mangiferin aglycon derivative, as well as preparation method and application of the mangiferin aglycon derivative SHANGHAI CHANGZHENG HOSPITAL 2013-03-13 CN claimed
EP-2477494-A1 NA/K-ATPASE LIGANDS, OUABAIN ANTAGONISTS, ASSAYS AND USES THEREOF The University of Toledo (US) 2012-07-25 EP claimed
CN-101429187-B Ketone compound, preparation method and application thereof CHONGQING INST OF TECHNOLOGY 2012-01-25 CN claimed
CN-102153536-A Mangiferin aglycon derivative, as well as preparation method and application of the mangiferin aglycon derivative SHANGHAI CHANGZHENG HOSPITAL 2011-08-17 CN claimed
WO-2011034772-A1 NA/K-ATPASE LIGANDS, OUABAIN ANTAGONISTS, ASSAYS AND USES THEREOF THE UNIVERSITY OF TOLEDO (US) 2011-03-24 WO claimed
CN-101429187-A Ketone compound, preparation method and application thereof CHONGQING INST OF TECHNOLOGY (CN) 2009-05-13 CN claimed
EP-0296625-A2 Agent for inhibiting binding of 5 alpha -dihydrotestosterone with androgen receptor as well as process for obtaining same Kabushiki Kaisha Vitamin Kenkyusyo (JP) 1988-12-28 EP claimed
CN-118126016-A Method for rapidly extracting xanthone isomer compound in cudrania tricuspidata 山东省分析测试中心 2024-06-04 CN disclosed
WO-2024029528-A1 PHARMACEUTICAL COMPOSITION FOR AMELIORATING ALLERGIC DISEASES 学校法人近畿大学 2024-02-08 WO disclosed
EP-3654841-B1 TARGETED OSMOTIC LYSIS OF MALIGNANT CANCER CELLS USING PULSED MAGNETIC FIELD GRADIENTS BOARD OF SUPERVISORS OF LOUISIANA STATE UNIV (US) 2024-02-07 EP disclosed
CN-1391928-A Medicine Qingyedan for curing hepatitis and its preparing method SHENGWUGU SCIENCE AND TECHNOLO (CN) 2003-01-22 CN disclosed
CN-1392128-A Process for preparing extract containing hypericin and flavon compounds UNIV ZHONGSHAN (CN) 2003-01-22 CN disclosed
US-5495005-A ANTICOAGULANTS, CARDIOVASCULAR DISORDERS NATIONAL SCIENCE COUNCIL (TW) 1996-02-27 US disclosed
EP-0296625-A2 Agent for inhibiting binding of 5 alpha -dihydrotestosterone with androgen receptor as well as process for obtaining same Kabushiki Kaisha Vitamin Kenkyusyo (JP) 1988-12-28 EP disclosed